128 related articles for article (PubMed ID: 2574717)
1. Functional aspects of three molecules associated with metastasis development in human malignant melanoma.
Johnson JP; Lehmann JM; Stade BG; Rothbächer U; Sers C; Riethmüller G
Invasion Metastasis; 1989; 9(6):338-50. PubMed ID: 2574717
[TBL] [Abstract][Full Text] [Related]
2. A study of adhesion molecules as markers of progression in malignant melanoma.
Denton KJ; Stretch JR; Gatter KC; Harris AL
J Pathol; 1992 Jun; 167(2):187-91. PubMed ID: 1378891
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the expression of intercellular adhesion molecule-1 and MUC18 on benign and malignant melanocytic lesions using monoclonal antibodies directed against distinct epitopes and recognizing denatured, non-glycosylated antigen.
Kraus A; Masat L; Johnson JP
Melanoma Res; 1997 Aug; 7 Suppl 2():S75-81. PubMed ID: 9578420
[TBL] [Abstract][Full Text] [Related]
4. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M
Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135
[TBL] [Abstract][Full Text] [Related]
5. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes.
Pickl WF; Majdic O; Fischer GF; Petzelbauer P; Faé I; Waclavicek M; Stöckl J; Scheinecker C; Vidicki T; Aschauer H; Johnson JP; Knapp W
J Immunol; 1997 Mar; 158(5):2107-15. PubMed ID: 9036955
[TBL] [Abstract][Full Text] [Related]
6. Influence of tumor-derived interleukin 1 on melanoma-endothelial cell interactions in vitro.
Burrows FJ; Haskard DO; Hart IR; Marshall JF; Selkirk S; Poole S; Thorpe PE
Cancer Res; 1991 Sep; 51(18):4768-75. PubMed ID: 1680022
[TBL] [Abstract][Full Text] [Related]
7. The role of CD146 (Mel-CAM) in biology and pathology.
Shih IM
J Pathol; 1999 Sep; 189(1):4-11. PubMed ID: 10451481
[TBL] [Abstract][Full Text] [Related]
8. Identification of molecules associated with the development of metastasis in human malignant melanoma.
Johnson JP
Invasion Metastasis; 1994-1995; 14(1-6):123-30. PubMed ID: 7657507
[TBL] [Abstract][Full Text] [Related]
9. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M
Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768
[TBL] [Abstract][Full Text] [Related]
10. MUC18, a melanoma-progression associated molecule, and its potential role in tumor vascularization and hematogenous spread.
Sers C; Riethmüller G; Johnson JP
Cancer Res; 1994 Nov; 54(21):5689-94. PubMed ID: 7923217
[TBL] [Abstract][Full Text] [Related]
11. Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ligand adhesion.
Shih IM; Speicher D; Hsu MY; Levine E; Herlyn M
Cancer Res; 1997 Sep; 57(17):3835-40. PubMed ID: 9288796
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells.
Altomonte M; Gloghini A; Bertola G; Gasparollo A; Carbone A; Ferrone S; Maio M
Cancer Res; 1993 Jul; 53(14):3343-8. PubMed ID: 7686816
[TBL] [Abstract][Full Text] [Related]
13. Phorbol ester and cyclic AMP-mediated regulation of the melanoma-associated cell adhesion molecule MUC18/MCAM.
Rummel MM; Sers C; Johnson JP
Cancer Res; 1996 May; 56(9):2218-23. PubMed ID: 8616875
[TBL] [Abstract][Full Text] [Related]
14. Ectopic expression of carcinoembryonic antigen by a melanoma cell leads to changes in the transcription of two additional cell adhesion molecules.
Grimm T; Johnson JP
Cancer Res; 1995 Aug; 55(15):3254-7. PubMed ID: 7614458
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions.
Natali PG; Hamby CV; Felding-Habermann B; Liang B; Nicotra MR; Di Filippo F; Giannarelli D; Temponi M; Ferrone S
Cancer Res; 1997 Apr; 57(8):1554-60. PubMed ID: 9108459
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of melanoma precursor lesions.
Wang Y; Rao U; Mascari R; Richards TJ; Panson AJ; Edington HD; Shipe-Spotloe JM; Donnelly SS; Kirkwood JM; Becker D
Cell Growth Differ; 1996 Dec; 7(12):1733-40. PubMed ID: 8959342
[TBL] [Abstract][Full Text] [Related]
17. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
[TBL] [Abstract][Full Text] [Related]
18. The differential reactivity of cells of the melanocytic lineage with four monoclonal antibodies against IFN-gamma inducible molecules.
Vacca A; Frassanito A; Rimoldi D; Dammacco F; Carrel S
Anticancer Res; 1992; 12(1):1-9. PubMed ID: 1348919
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of melanoma metastasis.
Bar-Eli M
J Cell Physiol; 1997 Nov; 173(2):275-8. PubMed ID: 9365536
[TBL] [Abstract][Full Text] [Related]
20. Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides.
Miele ME; Bennett CF; Miller BE; Welch DR
Exp Cell Res; 1994 Sep; 214(1):231-41. PubMed ID: 7915992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
